StockData
Atossa Therapeutics, Inc. logo

Atossa Therapeutics, Inc. (ATOS) stock

ATOSNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 6/30
$1.90−0.03 (-1.55%)

Close on Nov 17, 2026Market cap $18.96MP/E –Yield –

Atossa Therapeutics profit margin

Profit margin (net margin) is net income as a percentage of revenue.

Atossa Therapeutics's profit margin for the twelve months ending Sep 30, 2016 was -500957.3%. For fiscal 2015 it was -896491.6%, against -36518.8% the year before. The highest annual figure on record is -1054.3% in fiscal 2012.

Annual profit margin

PeriodPeriod endValueChange (pts)
FY2015Dec 31, 2015-896491.6%−859972.8
FY2014Dec 31, 2014-36518.8%−34813.9
FY2013Dec 31, 2013-1704.9%−650.7
FY2012Dec 31, 2012-1054.3%+228430.3
FY2011Dec 31, 2011-229484.5%–

More Atossa Therapeutics figures

See a number that looks wrong?